Cateria Bentley's story highlights a growing trend: women on GLP-1 weight loss drugs like Ozempic (semaglutide) experiencing unplanned pregnancies. While the news can be joyous, it's clouded by the lack of research on these drugs' safety during pregnancy.
Bentley, struggling with PCOS-related infertility, conceived after taking Mounjaro (a GLP-1 drug) for weight loss. This experience, echoed by many online under the term "Ozempic babies," raises concerns.
The Unknown Risk
Dr. Jody Dushay, an endocrinologist, emphasizes the lack of data on GLP-1 drugs' effects on fetuses. With these medications untested in pregnancy, the potential risks remain unknown.
What Doctors Recommend
Given the uncertainty, Dr. Dushay advises women planning pregnancy to stop taking GLP-1 drugs two months beforehand, as recommended by the prescribing information.
Considering Pregnancy While on GLP-1s?
Discuss your plans with your doctor.
Stop taking the medication well before conception.
Be aware of potential risks, though research is ongoing.
The Takeaway
While GLP-1 drugs offer significant weight loss benefits, their impact on pregnancy requires further study. Open communication with your doctor is crucial if you're considering pregnancy while on these medications.
Source: CNN
Comments